HIV resistance and viral diversity in new diagnoses
Part of Immune system & allergy, Infections clinical trials.
This study looks at HIV resistance and virus types in people who were just diagnosed with HIV and have not yet taken antiretroviral medications (except PrEP or PEP). It aims to better understand resistance patterns and track how HIV spreads.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You were just diagnosed with HIV (by a lab test) and your diagnosis was reported to public health
- You have not taken any HIV medications (except PrEP or PEP to prevent infection)
- You have a lab test showing the genetic makeup of your HIV (a resistance genotype that includes certain genes)
- You are okay with your data being used for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study that follows people to better understand how HIV and other infections (like sexually transmitted infections) happen and change over time. It may help researchers improve prevention and care, but it is mainly for monitoring rather than testing a new treatment.
This study enrolls people whose HIV infection is very recent or newly diagnosed (within the last few months). The researchers want to better understand early stages of HIV to improve how doctors identify and track new infections.
This is an observational study (not a new drug) that tracks how living with HIV can change over time in different treatment situations. It may help researchers understand long-term effects of the modern “protease inhibitor era” and improve future care.
This study looks at how the immune system and HIV behave in people on long-term HIV treatment (ART), using blood samples that will be stored for future tests for up to 20 years. It may help researchers understand how well treatment is controlling HIV and improve future care.
This study looks at rare types of HIV-1 (non-group M) in Cameroon. It uses stored blood samples and new tests to learn more about these strains, which may help improve treatment and understanding of the virus.
This study looks for drug-resistant HIV strains in people whose virus is not fully controlled by their current treatment. It aims to help doctors understand why the virus is still detectable.
Hear when a new HIV Seropositivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.